Literature DB >> 15542057

Oxidation of methionine residues in the prion protein by hydrogen peroxide.

Jesús R Requena1, Mariana N Dimitrova, Giuseppe Legname, Susana Teijeira, Stanley B Prusiner, Rodney L Levine.   

Abstract

Reaction of H(2)O(2) with the recombinant SHa(29-231) prion protein resulted in rapid oxidation of multiple methionine residues. Susceptibility to oxidation of individual residues, assessed by mass spectrometry after digestion with CNBr and lysC, was in general a function of solvent exposure. Met 109 and Met 112, situated in the highly flexible amino terminus, and key residues of the toxic peptide PrP (106-126), showed the greatest susceptibility. Met 129, a residue located in a polymorphic position in human PrP and modulating risk of prion disease, was also easily oxidized, as was Met 134. The structural effect of H(2)O(2)-induced methionine oxidation on PrP was studied by CD spectroscopy. As opposed to copper catalyzed oxidation, which results in extensive aggregation of PrP, this reaction led only to a modest increase in beta-sheet structure. The high number of solvent exposed methionine residues in PrP suggests their possible role as protective endogenous antioxidants.

Entities:  

Mesh:

Substances:

Year:  2004        PMID: 15542057     DOI: 10.1016/j.abb.2004.09.012

Source DB:  PubMed          Journal:  Arch Biochem Biophys        ISSN: 0003-9861            Impact factor:   4.013


  15 in total

1.  The structural intolerance of the PrP alpha-fold for polar substitution of the helix-3 methionines.

Authors:  Silvia Lisa; Massimiliano Meli; Gema Cabello; Ruth Gabizon; Giorgio Colombo; María Gasset
Journal:  Cell Mol Life Sci       Date:  2010-05-09       Impact factor: 9.261

2.  X-ray spectroscopic approaches to the investigation and characterization of photochemical processes.

Authors:  Pierre Kennepohl; Erik C Wasinger; Serena DeBeer George
Journal:  J Synchrotron Radiat       Date:  2009-06-17       Impact factor: 2.616

3.  Impact of methionine oxidation as an initial event on the pathway of human prion protein conversion.

Authors:  Mohammed I Y Elmallah; Uwe Borgmeyer; Christian Betzel; Lars Redecke
Journal:  Prion       Date:  2013-10-09       Impact factor: 3.931

4.  Peroxymonosulfate Rapidly Inactivates the Disease-Associated Prion Protein.

Authors:  Alexandra R Chesney; Clarissa J Booth; Christopher B Lietz; Lingjun Li; Joel A Pedersen
Journal:  Environ Sci Technol       Date:  2016-06-20       Impact factor: 9.028

5.  Structure of prion β-oligomers as determined by short-distance crosslinking constraint-guided discrete molecular dynamics simulations.

Authors:  Jason J Serpa; Konstantin I Popov; Evgeniy V Petrotchenko; Nikolay V Dokholyan; Christoph H Borchers
Journal:  Proteomics       Date:  2021-09-16       Impact factor: 5.393

6.  Detection of oxidized methionine in selected proteins, cellular extracts and blood serums by novel anti-methionine sulfoxide antibodies.

Authors:  Derek B Oien; Tamar Canello; Ruth Gabizon; Maria Gasset; Brandi L Lundquist; Jeff M Burns; Jackob Moskovitz
Journal:  Arch Biochem Biophys       Date:  2009-05-01       Impact factor: 4.013

7.  Design of anti- and pro-aggregation variants to assess the effects of methionine oxidation in human prion protein.

Authors:  Christina Wolschner; Armin Giese; Hans A Kretzschmar; Robert Huber; Luis Moroder; Nediljko Budisa
Journal:  Proc Natl Acad Sci U S A       Date:  2009-04-28       Impact factor: 11.205

8.  Methionine oxidation perturbs the structural core of the prion protein and suggests a generic misfolding pathway.

Authors:  Nadine D Younan; Rebecca C Nadal; Paul Davies; David R Brown; John H Viles
Journal:  J Biol Chem       Date:  2012-05-31       Impact factor: 5.157

9.  Prion-derived copper-binding peptide fragments catalyze the generation of superoxide anion in the presence of aromatic monoamines.

Authors:  Tomonori Kawano
Journal:  Int J Biol Sci       Date:  2006-11-09       Impact factor: 6.580

10.  Methionine sulfoxides on prion protein Helix-3 switch on the alpha-fold destabilization required for conversion.

Authors:  Giorgio Colombo; Massimiliano Meli; Giulia Morra; Ruth Gabizon; María Gasset
Journal:  PLoS One       Date:  2009-01-27       Impact factor: 3.240

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.